David P. Bonita's Insider Trades & SAST Disclosures
David P. Bonita's most recent trade in Repare Therapeutics Inc was a trade of 27,200 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 17, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David P. Bonita.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Repare Therapeutics Inc | David P. Bonita | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 27,200 | 27,200 | - | - | Stock Option (right to buy) | |
| Prelude Therapeutics Inc | David P. Bonita | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,500 | 23,500 | - | - | Director Stock Option (Right to Buy) | |
| Ikena Oncology Inc | David P. Bonita | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 17,520 | 17,520 | - | - | Stock Option (Right to Buy) | |
| Third Harmonic Bio Inc | David P. Bonita | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 20,000 | 20,000 | - | - | Director Stock Option (right to buy) | |
| Prelude Therapeutics Inc | David P. Bonita | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 23,500 | 23,500 | - | - | Director Stock Option (Right to Buy) | |
| Acutus Medical Inc | David P. Bonita | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 19,600 | 19,600 | - | - | FORM 4 | |
| Acutus Medical Inc | David P. Bonita | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 8,400 | 20,822 | - | 0 | FORM 4 | |
| Ikena Oncology Inc | David P. Bonita | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 17,520 | 17,520 | - | - | Stock Option (Right to Buy) | |
| Repare Therapeutics Inc | David P. Bonita | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 27,200 | 27,200 | - | - | Stock Option (right to buy) | |
| Third Harmonic Bio Inc | David P. Bonita | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 16,250 | 16,250 | - | - | Stock Option (right to buy) | |
| Prelude Therapeutics Inc | David P. Bonita | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.75 per share. | 22 May 2023 | 869,565 | 10,119,756 | - | 5.8 | 4,999,999 | Common Stock |
| Third Harmonic Bio Inc | David P. Bonita | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 13,667 | 0 | - | - | Employee Stock Option (right to buy) | |
| Third Harmonic Bio Inc | David P. Bonita | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 13,667 | 13,667 | - | - | Employee Stock Option (right to buy) | |
| Third Harmonic Bio Inc | David P. Bonita | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Oct 2022 | 13,667 | 13,667 | - | - | Stock Option (right to buy) | |
| Third Harmonic Bio Inc | David P. Bonita | Director, Ten Percent Owner | 19 Sep 2022 | 8,593,750 | 0 | - | - | Series A-2 Preferred Stock | ||
| Third Harmonic Bio Inc | David P. Bonita | Director, Ten Percent Owner | 19 Sep 2022 | 5,479,071 | 5,479,071 | - | - | Common Stock | ||
| Third Harmonic Bio Inc | David P. Bonita | Director, Ten Percent Owner | 19 Sep 2022 | 2,441,407 | 0 | - | - | Series A-3 Preferred Stock | ||
| Third Harmonic Bio Inc | David P. Bonita | Director, Ten Percent Owner | 19 Sep 2022 | 1,342,065 | 0 | - | - | Series B Preferred Stock | ||
| Third Harmonic Bio Inc | David P. Bonita | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 19 Sep 2022 | 300,000 | 5,779,071 | - | 17 | 5,100,000 | Common Stock |
| Ikena Oncology Inc | David P. Bonita | Director | Purchase of securities on an exchange or from another person at price $ 5.37 per share. | 22 Jun 2022 | 96,035 | 2,098,097 | - | 5.4 | 515,708 | Common Stock |
| Ikena Oncology Inc | David P. Bonita | Director | Purchase of securities on an exchange or from another person at price $ 3.55 per share. | 22 Jun 2022 | 66,806 | 1,912,678 | - | 3.5 | 237,161 | Common Stock |
| Ikena Oncology Inc | David P. Bonita | Director | Purchase of securities on an exchange or from another person at price $ 4.37 per share. | 22 Jun 2022 | 65,965 | 2,002,062 | - | 4.4 | 288,267 | Common Stock |
| Ikena Oncology Inc | David P. Bonita | Director | Purchase of securities on an exchange or from another person at price $ 3.71 per share. | 22 Jun 2022 | 23,419 | 1,936,097 | - | 3.7 | 86,884 | Common Stock |
| Prelude Therapeutics Inc | David P. Bonita | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 34,300 | 34,300 | - | - | Director Stock Option (Right to Buy) | |
| Acutus Medical Inc | David P. Bonita | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 19,600 | 19,600 | - | - | Stock Options (Right to Buy) | |
| Acutus Medical Inc | David P. Bonita | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,400 | 12,422 | - | 0 | Common Stock | |
| Ikena Oncology Inc | David P. Bonita | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 13,419 | 13,419 | - | - | Stock Option (Right to Buy) | |
| Repare Therapeutics Inc | David P. Bonita | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 49,000 | 49,000 | - | - | Stock Option (right to buy) | |
| Ikena Oncology Inc | David P. Bonita | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2021 | 13,419 | 13,419 | - | - | Stock Option (Right to Buy) | |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 34.00 per share. | 03 Sep 2021 | 6,985 | 3,177,902 | - | 34 | 237,490 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 33.93 per share. | 03 Sep 2021 | 861 | 3,177,041 | - | 33.9 | 29,214 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 34.00 per share. | 03 Sep 2021 | 212 | 96,216 | - | 34 | 7,208 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 33.92 per share. | 03 Sep 2021 | 26 | 96,190 | - | 33.9 | 882 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 34.24 per share. | 31 Aug 2021 | 15,941 | 3,184,887 | - | 34.2 | 545,820 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 33.98 per share. | 31 Aug 2021 | 12,586 | 3,200,828 | - | 34.0 | 427,672 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 33.94 per share. | 31 Aug 2021 | 8,223 | 3,213,414 | - | 33.9 | 279,089 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 34.24 per share. | 31 Aug 2021 | 483 | 96,428 | - | 34.2 | 16,538 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 33.98 per share. | 31 Aug 2021 | 382 | 96,911 | - | 34.0 | 12,980 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 33.94 per share. | 31 Aug 2021 | 249 | 97,293 | - | 33.9 | 8,451 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 33.94 per share. | 26 Aug 2021 | 6,884 | 3,228,137 | - | 33.9 | 233,643 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 33.92 per share. | 26 Aug 2021 | 6,500 | 3,221,637 | - | 33.9 | 220,480 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 34.52 per share. | 26 Aug 2021 | 4,157 | 3,235,021 | - | 34.5 | 143,500 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 33.94 per share. | 26 Aug 2021 | 209 | 97,739 | - | 33.9 | 7,093 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 33.92 per share. | 26 Aug 2021 | 197 | 97,542 | - | 33.9 | 6,682 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 34.52 per share. | 26 Aug 2021 | 126 | 97,948 | - | 34.5 | 4,350 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 34.06 per share. | 23 Aug 2021 | 6,885 | 3,249,972 | - | 34.1 | 234,503 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 34.34 per share. | 23 Aug 2021 | 6,874 | 3,239,178 | - | 34.3 | 236,053 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 34.07 per share. | 23 Aug 2021 | 3,920 | 3,246,052 | - | 34.1 | 133,554 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 34.06 per share. | 23 Aug 2021 | 209 | 98,401 | - | 34.1 | 7,119 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 34.34 per share. | 23 Aug 2021 | 208 | 98,074 | - | 34.3 | 7,143 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 34.07 per share. | 23 Aug 2021 | 119 | 98,282 | - | 34.1 | 4,054 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 34.12 per share. | 17 Aug 2021 | 16,886 | 3,259,439 | - | 34.1 | 576,150 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 34.12 per share. | 17 Aug 2021 | 16,886 | 3,259,439 | - | 34.1 | 576,150 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 33.99 per share. | 17 Aug 2021 | 2,852 | 3,256,857 | - | 34.0 | 96,939 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 33.99 per share. | 17 Aug 2021 | 2,852 | 3,256,857 | - | 34.0 | 96,939 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 34.12 per share. | 17 Aug 2021 | 512 | 98,688 | - | 34.1 | 17,469 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 34.12 per share. | 17 Aug 2021 | 512 | 98,688 | - | 34.1 | 17,469 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 33.99 per share. | 17 Aug 2021 | 78 | 98,610 | - | 34.0 | 2,651 | Common Stock |
| Repare Therapeutics Inc | David P. Bonita | Director | Sale of securities on an exchange or to another person at price $ 33.99 per share. | 17 Aug 2021 | 78 | 98,610 | - | 34.0 | 2,651 | Common Stock |
| Acutus Medical Inc | David P. Bonita | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.00 per share. | 19 Jul 2021 | 714,285 | 4,872,025 | - | 14 | 9,999,990 | Common Stock |
| Acutus Medical Inc | David P. Bonita | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.00 per share. | 19 Jul 2021 | 357,143 | 1,677,361 | - | 14 | 5,000,002 | Common Stock |
| Prelude Therapeutics Inc | David P. Bonita | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 23,344 | 23,344 | - | - | Director Stock Option (Right to Buy) | |
| Acutus Medical Inc | David P. Bonita | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 7,022 | 7,022 | - | - | Stock Options (Right to Buy) | |
| Acutus Medical Inc | David P. Bonita | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 1,800 | 4,022 | - | 0 | Common Stock | |
| Repare Therapeutics Inc | David P. Bonita | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 21,000 | 21,000 | - | - | Stock Option (right to buy) | |
| Ikena Oncology Inc | David P. Bonita | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2021 | 8,938,148 | 8,938,148 | - | - | Series B Preferred Stock | |
| Ikena Oncology Inc | David P. Bonita | Director | 30 Mar 2021 | 5,429,023 | 5,429,023 | - | - | Non-Voting Common Stock | ||
| Ikena Oncology Inc | David P. Bonita | Director | 30 Mar 2021 | 2,411,260 | 0 | - | - | Series A-1 Preferred Stock | ||
| Ikena Oncology Inc | David P. Bonita | Director | 30 Mar 2021 | 2,034,708 | 0 | - | - | Series A Preferred Stock | ||
| Ikena Oncology Inc | David P. Bonita | Director | 30 Mar 2021 | 1,470,872 | 1,470,872 | - | - | Common Stock | ||
| Ikena Oncology Inc | David P. Bonita | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2021 | 1,430,103 | 1,430,103 | - | - | Series B Preferred Stock | |
| Ikena Oncology Inc | David P. Bonita | Director | 30 Mar 2021 | 983,054 | 0 | - | - | Series B Preferred Stock | ||
| Ikena Oncology Inc | David P. Bonita | Director | 30 Mar 2021 | 653,277 | 0 | - | - | Series A-1 Preferred Stock | ||
| Ikena Oncology Inc | David P. Bonita | Director | 30 Mar 2021 | 551,259 | 0 | - | - | Series A Preferred Stock | ||
| Ikena Oncology Inc | David P. Bonita | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 30 Mar 2021 | 375,000 | 1,845,872 | - | 16 | 6,000,000 | Common Stock |
| Ikena Oncology Inc | David P. Bonita | Director | 30 Mar 2021 | 266,337 | 0 | - | - | Series B Preferred Stock | ||
| Ikena Oncology Inc | David P. Bonita | Director | 30 Mar 2021 | 157,288 | 157,288 | - | - | Non-Voting Common Stock | ||
| Ikena Oncology Inc | David P. Bonita | Director | 30 Mar 2021 | 157,288 | 0 | - | - | Series B Preferred Stock | ||
| Ikena Oncology Inc | David P. Bonita | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 30 Mar 2021 | 48,400 | 91,014 | - | 16 | 774,400 | Common Stock |
| Ikena Oncology Inc | David P. Bonita | Director | 30 Mar 2021 | 42,614 | 42,614 | - | - | Common Stock | ||
| Ikena Oncology Inc | David P. Bonita | Director | 30 Mar 2021 | 42,614 | 0 | - | - | Series B Preferred Stock | ||
| Prelude Therapeutics Inc | David P. Bonita | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Jan 2021 | 41,700 | 5,596,886 | - | - | Non-Voting Common Stock | |
| Acutus Medical Inc | David P. Bonita | Director, Ten Percent Owner | 10 Aug 2020 | 3,784,240 | 4,157,740 | - | 0 | Common Stock | ||
| Acutus Medical Inc | David P. Bonita | Director, Ten Percent Owner | 10 Aug 2020 | 1,278,718 | 1,320,218 | - | 0 | Common Stock | ||
| Acutus Medical Inc | David P. Bonita | Director, Ten Percent Owner | 10 Aug 2020 | 1,202,117 | 0 | - | - | Series D Convertible Preferred Stock | ||
| Acutus Medical Inc | David P. Bonita | Director, Ten Percent Owner | 10 Aug 2020 | 899,985 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Acutus Medical Inc | David P. Bonita | Director, Ten Percent Owner | 10 Aug 2020 | 872,302 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Acutus Medical Inc | David P. Bonita | Director, Ten Percent Owner | 10 Aug 2020 | 673,123 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Acutus Medical Inc | David P. Bonita | Director, Ten Percent Owner | 10 Aug 2020 | 647,582 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Acutus Medical Inc | David P. Bonita | Director, Ten Percent Owner | 10 Aug 2020 | 389,116 | 0 | - | - | Series D Convertible Preferred Stock | ||
| Acutus Medical Inc | David P. Bonita | Director, Ten Percent Owner | 10 Aug 2020 | 378,733 | 0 | - | - | Series D Convertible Preferred Stock | ||
| Acutus Medical Inc | David P. Bonita | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 10 Aug 2020 | 373,500 | 373,500 | - | 18 | 6,723,000 | Common Stock |
| Acutus Medical Inc | David P. Bonita | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 10 Aug 2020 | 41,500 | 41,500 | - | 18 | 747,000 | Common Stock |
| Acutus Medical Inc | David P. Bonita | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 12,454 | 12,454 | - | - | Stock Options (Right to Buy) | |
| Acutus Medical Inc | David P. Bonita | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 2,222 | 2,222 | - | 0 | Common Stock | |
| Repare Therapeutics Inc | David P. Bonita | Director | 23 Jun 2020 | 2,601,325 | 0 | - | - | Class B Preferred Shares | ||
| Repare Therapeutics Inc | David P. Bonita | Director | 23 Jun 2020 | 2,601,325 | 2,601,325 | - | - | Common Shares | ||
| Repare Therapeutics Inc | David P. Bonita | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 23 Jun 2020 | 675,000 | 3,276,325 | - | 20 | 13,500,000 | Common Shares |
| Repare Therapeutics Inc | David P. Bonita | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 23 Jun 2020 | 99,200 | 99,200 | - | 20 | 1,984,000 | Common Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges